Literature DB >> 23356788

Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface.

Wanachat Chaiyasan1, Sangly P Srinivas, Waree Tiyaboonchai.   

Abstract

PURPOSE: To characterize nanoparticles produced by self-assembly of oppositely charged polymers, cationic chitosan (CS), and anionic dextran sulfate (DS), for drug delivery to the ocular surface. The goal is to overcome the short residence time of topical drugs through their sustained release from mucoadhesive nanoparticles.
METHODS: Chitosan-dextran sulfate nanoparticles (CDNs) were produced by mixing CS and DS; polyethylene glycol-400 was used as a surface stabilizing agent. Fourier transform infrared spectroscopy (FTIR) spectra of CS, DS, and CDNs were determined in the wavenumber range of 4,000-700 cm(-1) to assess the ionic interactions in the formation of CDNs. The physicochemical properties, entrapment efficacy, and dissolution profile of CDNs were investigated using Rhodamine B (RhB) and Nile Red (NR) as drug analogs. The mucoadhesiveness of the CDNs was assessed by imaging the retention of the fluorescein isothiocyanate-labeled CDNs on the cornea ex vivo, which was subjected to shear stress by a steady stream of saline solution.
RESULTS: CDNs were obtained by the polyelectrolyte complexation technique. The FTIR spectra of CDNs showed spectral shifts in the amine and sulfate regions, confirming an involvement of electrostatic interactions between cationic CS and anionic DS. The CDNs were spherical in shape and segregated. They possessed a particle size of ~400 nm with a polydispersity index of 0.3 and exhibited a zeta potential of ~40 mV. A high entrapment efficacy of up to 80% was observed with both RhB and NR. In the dissolution experiments, NR was released from CDNs within 60 min, but RhB was not released. This indicates that the release of drugs could depend on their molecular interactions with the particle. Exposure of CDNs to lysozyme, which is found in tears, had no effect on the mean particle size or the surface charge. Instillation of NR, RhB, and FITC in the presence of saline irrigation resulted in their rapid disappearance (<5 min) from the corneal surface. In contrast, fluorescent CDNs showed retention on the cornea even after 60 min.
CONCLUSIONS: Cationic and biocompatible mucoadhesive CDNs have been developed for sustained drug delivery to the ocular surface. The CDNs were stable to lysozyme and showed prolonged adherence to the corneal surface.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23356788      PMCID: PMC3601816          DOI: 10.1089/jop.2012.0193

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  32 in total

1.  Shear-induced ATP release by cultured rabbit corneal epithelial cells.

Authors:  S P Srinivas; R Mutharasan; S Fleiszig
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

2.  Effect of hydroxypropyl-β-cyclodextrin on the ocular bioavailability of dexamethasone from a pH-induced mucoadhesive hydrogel.

Authors:  Karthikeyan Kesavan; Shri Kant; Paras Nath Singh; Jayanta Kumar Pandit
Journal:  Curr Eye Res       Date:  2011-10       Impact factor: 2.424

Review 3.  The use of mucoadhesive polymers in ocular drug delivery.

Authors:  Annick Ludwig
Journal:  Adv Drug Deliv Rev       Date:  2005-09-28       Impact factor: 15.470

4.  Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: In vitro and pharmacokinetics studies.

Authors:  R S Bhatta; H Chandasana; Y S Chhonker; C Rathi; D Kumar; K Mitra; P K Shukla
Journal:  Int J Pharm       Date:  2012-04-28       Impact factor: 5.875

5.  Chitosan nanoparticle-based neuronal membrane sealing and neuroprotection following acrolein-induced cell injury.

Authors:  Youngnam Cho; Riyi Shi; Richard Ben Borgens
Journal:  J Biol Eng       Date:  2010-01-29       Impact factor: 4.355

6.  Preliminary studies on the development of IgA-loaded chitosan-dextran sulphate nanoparticles as a potential nasal delivery system for protein antigens.

Authors:  Sameer Sharma; Heather A E Benson; Trilochan K S Mukkur; Paul Rigby; Yan Chen
Journal:  J Microencapsul       Date:  2012-09-21       Impact factor: 3.142

7.  Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation.

Authors:  William F Davitt; Marc Bloomenstein; Mike Christensen; Anna E Martin
Journal:  J Ocul Pharmacol Ther       Date:  2010-08       Impact factor: 2.671

8.  Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles.

Authors:  Waree Tiyaboonchai; Nanteetip Limpeanchob
Journal:  Int J Pharm       Date:  2006-08-17       Impact factor: 5.875

Review 9.  Recent advances in ophthalmic drug delivery.

Authors:  Uday B Kompella; Rajendra S Kadam; Vincent H L Lee
Journal:  Ther Deliv       Date:  2010-09

10.  Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time.

Authors:  Young Bin Choy; Jung-Hwan Park; Bernard E McCarey; Henry F Edelhauser; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-08       Impact factor: 4.799

View more
  11 in total

Review 1.  Nanoparticles for drug delivery to the anterior segment of the eye.

Authors:  Dileep R Janagam; Linfeng Wu; Tao L Lowe
Journal:  Adv Drug Deliv Rev       Date:  2017-04-06       Impact factor: 15.470

Review 2.  Chitosan Nanoparticles in Atherosclerosis-Development to Preclinical Testing.

Authors:  Pornsak Sriamornsak; Crispin R Dass
Journal:  Pharmaceutics       Date:  2022-04-25       Impact factor: 6.525

Review 3.  Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.

Authors:  Anil Kumar; Fei Chen; Anbu Mozhi; Xu Zhang; Yuanyuan Zhao; Xiangdong Xue; Yanli Hao; Xiaoning Zhang; Paul C Wang; Xing-Jie Liang
Journal:  Nanoscale       Date:  2013-09-21       Impact factor: 7.790

4.  Chitosan grafted methoxy poly(ethylene glycol)-poly(ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac.

Authors:  Shuai Shi; Zhaoliang Zhang; Zichao Luo; Jing Yu; Renlong Liang; Xingyi Li; Hao Chen
Journal:  Sci Rep       Date:  2015-06-12       Impact factor: 4.379

5.  Immunogenic Properties of a BCG Adjuvanted Chitosan Nanoparticle-Based Dengue Vaccine in Human Dendritic Cells.

Authors:  Taweewun Hunsawong; Panya Sunintaboon; Saradee Warit; Butsaya Thaisomboonsuk; Richard G Jarman; In-Kyu Yoon; Sukathida Ubol; Stefan Fernandez
Journal:  PLoS Negl Trop Dis       Date:  2015-09-22

6.  Gelatin-epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief.

Authors:  Hsin-Yi Huang; Ming-Chen Wang; Zhi-Yu Chen; Wen-Ying Chiu; Ko-Hua Chen; I-Chan Lin; Wei-Chung Vivian Yang; Chi-Chang Wu; Ching-Li Tseng
Journal:  Int J Nanomedicine       Date:  2018-11-08

7.  Development of In Vitro Methodologies to Investigate Binding by Sodium Hyaluronate in Eye Drops to Corneal Surfaces.

Authors:  Udo Bock; Von Deylen D; Jochner M; Doerr M; Stäbler C; Reichl S
Journal:  Open Ophthalmol J       Date:  2018-07-31

8.  Tacrolimus Loaded Cationic Liposomes for Dry Eye Treatment.

Authors:  Xiang Chen; Jicheng Wu; Xueqi Lin; Xingdi Wu; Xuewen Yu; Ben Wang; Wen Xu
Journal:  Front Pharmacol       Date:  2022-02-04       Impact factor: 5.810

9.  Crosslinked chitosan-dextran sulfate nanoparticle for improved topical ocular drug delivery.

Authors:  Wanachat Chaiyasan; Sangly P Srinivas; Waree Tiyaboonchai
Journal:  Mol Vis       Date:  2015-10-26       Impact factor: 2.367

10.  Complex Polysaccharide-Based Nanocomposites for Oral Insulin Delivery.

Authors:  Mar Collado-González; M Cristina Ferreri; Alessandra R Freitas; Ana Cláudia Santos; Nuno R Ferreira; Guzmán Carissimi; Joana A D Sequeira; F Guillermo Díaz Baños; Gloria Villora; Francisco Veiga; Antonio Ribeiro
Journal:  Mar Drugs       Date:  2020-01-15       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.